BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Missiroli S, Perrone M, Boncompagni C, Borghi C, Campagnaro A, Marchetti F, Anania G, Greco P, Fiorica F, Pinton P, Giorgi C. Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer. Cancers (Basel) 2021;13:2297. [PMID: 34064909 DOI: 10.3390/cancers13102297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Scuderi SA, Casili G, Basilotta R, Lanza M, Filippone A, Raciti G, Puliafito I, Colarossi L, Esposito E, Paterniti I. NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression. Int J Mol Sci 2021;22:11108. [PMID: 34681768 DOI: 10.3390/ijms222011108] [Reference Citation Analysis]
2 Propper DJ, Balkwill FR. Harnessing cytokines and chemokines for cancer therapy. Nat Rev Clin Oncol 2022. [PMID: 34997230 DOI: 10.1038/s41571-021-00588-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 24.0] [Reference Citation Analysis]
3 Perrone M, Raimondi E, Costa M, Rasetto G, Rizzati R, Lanza G, Gafà R, Cavallesco G, Tamburini N, Maniscalco P, Mantovani MC, Tebano U, Coeli M, Missiroli S, Tilli M, Pinton P, Giorgi C, Fiorica F. Inflammatory Microenvironment in Early Non-Small Cell Lung Cancer: Exploring the Predictive Value of Radiomics. Cancers 2022;14:3335. [DOI: 10.3390/cancers14143335] [Reference Citation Analysis]
4 Dhanjal CR, Lingamsetty R, Pareddy A, Kim S, Raval R. Dual Role of Chitin as the Double Edged Sword in Controlling the NLRP3 Inflammasome Driven Gastrointestinal and Gynaecological Tumours. Marine Drugs 2022;20:452. [DOI: 10.3390/md20070452] [Reference Citation Analysis]
5 Theivanthiran B, Haykal T, Cao L, Holtzhausen A, Plebanek M, DeVito NC, Hanks BA. Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis. Cancers (Basel) 2021;13:4753. [PMID: 34638239 DOI: 10.3390/cancers13194753] [Reference Citation Analysis]
6 Andrieux P, Chevillard C, Cunha-Neto E, Nunes JPS. Mitochondria as a Cellular Hub in Infection and Inflammation. Int J Mol Sci 2021;22:11338. [PMID: 34768767 DOI: 10.3390/ijms222111338] [Reference Citation Analysis]
7 Pizzuto M, Pelegrin P, Ruysschaert JM. Lipid-protein interactions regulating the canonical and the non-canonical NLRP3 inflammasome. Prog Lipid Res 2022;87:101182. [PMID: 35901922 DOI: 10.1016/j.plipres.2022.101182] [Reference Citation Analysis]
8 Eddy K, Chen S. Glutamatergic Signaling a Therapeutic Vulnerability in Melanoma. Cancers (Basel) 2021;13:3874. [PMID: 34359771 DOI: 10.3390/cancers13153874] [Reference Citation Analysis]